Amphastar Pharmaceuticals, Inc. Financial Ratios — 29A Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	4.89	-4.01	-0.97	3.14	1.1	-1.72	13.71	0.36	14.65	18.76	23.55	23.26	12.9
Return on Assets (%)	- -	- -	3.62	-2.94	-0.72	2.4	0.83	-1.19	8.89	0.23	9.54	12.93	12.2	10.32	6.12
Return on Capital (%)	- -	- -	4.51	- -	- -	2.99	- -	- -	11.33	0.36	11.56	15.72	16.86	13.99	8.37
Return on Invested Capital (%)	- -	- -	4.29	- -	- -	2.89	- -	- -	-0.01	0.51	9.83	14.41	16.93	13.07	7.87
Gross Margin (%)	23.75	44.2	37.86	24.35	30.75	40.83	37.68	36.31	40.92	40.97	45.63	49.87	54.49	51.08	49.46
EBITDA Margin (%)	-18.92	18.06	13.31	-1.68	2.53	11.78	6.05	2.68	6.54	10.33	22.03	27.21	37.05	35.88	28.28
Operating Margin (%)	-28.29	13.45	7.67	-8.54	-2.74	6.03	-1.63	-2.93	-0.01	3.13	15.96	21.54	30.57	28.06	19.5
Incremental Operating Margin (%)	- -	70.92	- -	185.22	27	610.92	128.67	- -	31	39.99	67.03	61.44	61.54	9.63	538.21
Pretax Margin (%)	-26.94	12.67	7.5	-8.62	-4.12	5.73	0.52	-3.37	18.68	1.33	19.22	23.26	26.59	25.93	17.17
Profit Margin (%)	6.55	8.86	5.16	-5.08	-1.11	3.85	1.52	-1.95	15.18	0.4	14.19	18.31	21.34	21.79	13.63
Net Income to Common Margin (%)	6.55	8.86	5.16	-5.08	-1.11	3.85	1.52	-1.95	15.18	0.4	14.19	18.31	21.34	21.79	13.63
Effective Tax Rate (%)	- -	30.08	31.14	- -	- -	32.88	- -	- -	22.79	76.34	24.52	20.23	18.58	15.64	20.65
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	4.89	-4.01	-0.97	3.14	1.1	-1.72	13.71	0.36	14.65	18.76	23.55	23.26	12.9

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	38	32	44	41	38	47	50	67	67	105	103	624	651	656
ST Debt	- -	22	22	8	11	5	6	18	11	16	5	6	4	7	10
LT Debt	- -	16	10	36	30	32	41	32	56	52	99	97	619	644	646
Total Debt/EBITDA	- -	1.03	1.05	-12.36	6.47	1.26	3.24	6.36	3.16	1.86	1.09	0.76	2.61	2.48	3.22
Net Debt/EBITDA	- -	-0.33	-0.7	6.83	-3.93	-1.15	-1.27	-4.58	-1.26	-1.28	-0.51	-0.59	1.87	1.71	2.16
Total Debt/EBIT	- -	1.5	1.84	-2.43	-5.96	2.45	-37.16	-5.82	-1,708.33	6.14	1.5	0.95	3.17	3.17	4.67
Net Debt/EBIT	- -	-0.48	-1.22	1.34	3.62	-2.25	14.53	4.19	680.77	-4.22	-0.71	-0.75	2.26	2.19	3.14
EBITDA to Interest Expense	-38.35	47.06	31.91	-5.8	6.44	29.35	17.6	32.48	177.16	96.61	108.95	73.55	8.79	8.66	7.99
EBITDA-CapEx/Interest Expense	-55.42	15.63	13.49	-39.46	-9.77	8.47	-24.89	-160.14	-172.04	6.09	77.93	60.53	7.39	7.3	6.53
EBIT to Interest Expense	-57.33	35.07	18.39	-29.53	-6.99	15.02	-4.74	-35.49	-0.33	29.29	78.97	58.23	7.25	6.77	5.51
Interest Expense	1	1	1	1	1	1	1	- -	- -	- -	1	2	27	30	25
Common Equity/Total Assets	- -	73.53	74.26	72.39	75.75	76.98	73.99	64.73	64.97	63.73	66.34	71.25	42.26	46.42	48.41
Long-Term Debt/Equity (%)	- -	6.83	4	12.81	10.21	9.83	12.24	8.78	13.03	11.51	22.33	18.26	96.85	87.88	81.95
Long-Term Debt/Capital (%)	- -	5.88	3.55	11.09	8.96	8.82	10.72	7.71	11.27	10.01	18.08	15.29	49.03	46.54	44.74
Long-Term Debt/Total Assets (%)	- -	5.02	2.97	9.27	7.73	7.56	9.05	6.23	9.49	8.18	14.81	13.01	40.93	40.79	39.68
Total Debt/Equity (%)	- -	16.28	12.79	15.5	13.91	11.46	14.13	13.78	15.58	14.99	23.49	19.4	97.53	88.84	83.16
Total Debt/Capital (%)	- -	14	11.34	13.42	12.21	10.28	12.38	12.11	13.48	13.04	19.02	16.25	49.38	47.04	45.4
Total Debt/Total Assets (%)	- -	11.97	9.5	11.22	10.53	8.82	10.45	9.78	11.35	10.66	15.59	13.83	41.22	41.24	40.26
Net Debt to Equity	- -	-5.23	-8.51	-8.56	-8.45	-10.52	-5.52	-9.91	-6.21	-10.29	-11.08	-15.17	69.71	61.49	55.81
Net Debt/Capital (%)	- -	-5.52	-9.31	-9.36	-9.23	-11.75	-5.85	-11.01	-6.31	-10.91	-11.65	-16.88	39.84	36.57	34.54
EBITDA	-22	37	31	-4	6	30	15	8	21	36	96	136	239	263	204
EBITDA-CapEx	-32	12	13	-24	-10	9	-21	-39	-20	2	69	112	201	222	166
Operating Income (Loss)	-33	27	18	-18	-7	15	-4	-9	- -	11	70	107	197	205	140

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.84	0.82	1.08	1.1	1.2	1.02	0.83	0.95	0.94	1.32	1.85	1.14	1.28	1.79
Current Ratio	- -	2.76	2.64	3.16	2.93	3.04	2.79	2.06	2.84	2.49	3.06	3.99	2.17	3.07	4.02
Quick Ratio	- -	1.47	1.23	1.45	1.66	1.64	1.64	1.32	1.46	1.53	2.08	2.79	1.65	2.07	2.8
CFO/Avg Current Liab	- -	- -	0.49	0.33	0.17	0.64	0.61	0.44	0.42	0.57	0.91	0.9	1.15	1.07	0.94
Common Equity/Total Assets	- -	73.53	74.26	72.39	75.75	76.98	73.99	64.73	64.97	63.73	66.34	71.25	42.26	46.42	48.41
Long-Term Debt/Equity (%)	- -	6.83	4	12.81	10.21	9.83	12.24	8.78	13.03	11.51	22.33	18.26	96.85	87.88	81.95
Long-Term Debt/Capital (%)	- -	5.88	3.55	11.09	8.96	8.82	10.72	7.71	11.27	10.01	18.08	15.29	49.03	46.54	44.74
Long-Term Debt/Total Assets (%)	- -	5.02	2.97	9.27	7.73	7.56	9.05	6.23	9.49	8.18	14.81	13.01	40.93	40.79	39.68
Total Debt/Equity (%)	- -	16.28	12.79	15.5	13.91	11.46	14.13	13.78	15.58	14.99	23.49	19.4	97.53	88.84	83.16
Total Debt/Capital (%)	- -	14	11.34	13.42	12.21	10.28	12.38	12.11	13.48	13.04	19.02	16.25	49.38	47.04	45.4
Total Debt/Total Assets (%)	- -	11.97	9.5	11.22	10.53	8.82	10.45	9.78	11.35	10.66	15.59	13.83	41.22	41.24	40.26
CFO/Total Liabilities	- -	-1.96	35.6	19.58	11.29	39.15	33.42	25.6	26.19	31.38	43.36	41.8	21.01	25.25	18.57
CFO/CapEx	1.92	-0.07	1.76	1.03	0.67	1.8	1.12	0.82	1	1.69	3.57	3.71	4.81	5.2	4.2
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.09	4.49	3.93	3.39

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	7.53	8.87	8.97	8.5	7.65	6.68	6.61	6.28	6.05	5.95	6.33	5.83	5.14
Days Sales Outstanding	- -	- -	48.46	41.13	40.69	42.92	47.7	54.6	55.22	58.1	60.37	61.3	57.7	62.64	70.95
Inventory Turnover	- -	- -	2.35	2.09	2.28	2.01	2.09	2.82	2.12	1.99	2.51	2.55	2.8	2.76	2.2
Days Inventory Outstanding	- -	- -	155.1	174.53	160.31	181.84	174.81	129.26	172.33	183.23	145.4	143.29	130.32	132.28	165.85
Accounts Payable Turnover	- -	- -	8.48	11.24	13.52	9.47	7.3	8.07	8.22	7.8	10.05	12.22	12.87	14.51	12.26
Accounts Payable Turnover Days	- -	- -	43.05	32.48	26.99	38.54	49.97	45.25	44.43	46.77	36.32	29.88	28.37	25.15	29.76
Cash Conversion Cycle	- -	- -	160.51	183.18	174.02	186.21	172.54	138.61	183.12	194.56	169.45	174.71	159.65	169.77	207.03
Inventory to Cash Days	- -	- -	-106.63	-133.39	-119.62	-138.91	-127.12	-74.66	-117.11	-125.13	-85.03	-81.99	-72.61	-69.64	-94.9
Inventories	- -	51	70	82	71	80	64	69	111	97	93	104	106	154	177
Raw Materials	- -	29	34	42	30	36	20	30	59	47	42	48	50	82	107
Work In Process	- -	9	15	16	26	22	22	30	36	37	33	37	31	33	40
Finished Goods	- -	19	27	25	15	21	21	9	16	13	18	19	25	39	30
Other Inventory	- -	- -	- -	- -	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,370	2,998	1,776	1,207
- Cash & Cash Equivalents	- -	50	54	68	66	72	66	86	74	93	126	156	144	152	170
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	32	46	46	- -	- -	- -	- -	- -
+ Total Debt	- -	38	32	44	41	38	47	50	67	67	105	103	624	651	656
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,297	3,365	2,205	1,580
Total Capital	- -	271	284	326	337	367	381	415	494	516	550	631	1,263	1,383	1,445
Total Debt/Capital (%)	- -	14	11.34	13.42	12.21	10.28	12.38	12.11	13.48	13.04	19.02	16.25	49.38	47.04	45.4
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.08	0.19	0.3	0.42
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.6	5.22	3.01	2.2
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.55	14.09	8.4	7.76
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.07	17.08	10.73	11.26
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.31	16.36	9.23	8.96
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.47	20.09	11.14	11.35
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,493	3,306	1,942	1,275
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,420	3,672	2,371	1,648
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.96	70	46.31	34.62
TTM Sales	118	204	230	210	252	255	240	295	322	350	438	499	644	732	720
TTM EBITDA	-22	37	31	-4	6	30	15	8	21	36	96	136	239	263	204
TTM Operating Income	-33	27	18	-18	-7	15	-4	-9	- -	11	70	107	197	205	140
TTM Cash Flow to Firm	- -	-1	32	- -	- -	39	- -	- -	42	57	99	91	206	239	176
TTM Free Cash Flow to Firm	- -	-26	14	- -	- -	18	- -	- -	- -	23	71	67	167	198	139

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.92	22.74	11.27	10.72
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.07	17.08	10.73	11.26
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,297	3,365	2,205	1,580
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.24	27.78	36.66	20.42
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.6	5.22	3.01	2.2
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.55	14.09	8.4	7.76
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.13	21.89	11.32	12.6
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.38	16.2	13.92	12.93
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.13	23.69	19.61	18.41
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.47	9.75	11.13	9.73
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.59	4.69	2.43	1.53
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.98	3.47	2.98	1.57
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.96	5.08	4.2	2.24
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.48	2.09	2.38	1.18
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.79	114.75	12.54	5.42
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.2	84.95	15.41	5.56
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.26	124.22	21.72	7.91
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.67	51.12	12.32	4.18
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.77	4.67	2.47	1.72
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.18	3.46	3.03	1.76
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.24	5.06	4.27	2.51
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.65	2.08	2.43	1.33
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.51	16.4	8.47	7.92
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.81	12.14	10.4	8.12
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.7	17.76	14.66	11.57
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.83	7.31	8.32	6.11
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.33	16.84	13.85	10.99
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	35.03	24.62	19.51	15.66
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21.92	10.13	11.07	8.27
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.01	4.01	3.57	2.24
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.05	5.61	4.79	2.97
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.48	2.64	2.97	1.81
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.06	10.83	9.94	7.91
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.89	15.13	13.35	10.49
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.11	7.13	8.28	6.41
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.96	13.13	12.71	11.48
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.8	18.34	17.06	15.22
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.51	8.64	10.59	9.3
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.48	62.37	37.3	26.45
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	43.53	67.52	64.6	38.64
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,501	2,586	2,612	1,612
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2,021	3,612	3,505	2,137
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,237	1,702	2,174	1,305

Shares Outstanding	43	43	45	45	45	46	47	47	47	47	48	48	48	48	46
Diluted Weighted Avg Shares	8	8	8	42	45	48	48	46	50	49	50	52	53	52	48
Basic Weighted Avg Shares	8	8	8	42	45	45	46	46	47	47	48	49	48	48	47
Revenue per Share	14.79	25.54	28.71	5.02	5.59	5.62	5.21	6.35	6.86	7.44	9.16	10.28	13.35	15.11	15.4
EBITDA per Share	-2.8	4.61	3.82	-0.08	0.14	0.66	0.32	0.17	0.45	0.77	2.02	2.8	4.95	5.42	4.36
Operating Income per Share	-4.18	3.44	2.2	-0.43	-0.15	0.34	-0.08	-0.19	- -	0.23	1.46	2.21	4.08	4.24	3
Basic EPS, GAAP	0.97	2.26	1.48	-0.25	-0.06	0.22	0.08	-0.12	1.04	0.03	1.3	1.88	2.85	3.29	2.1
Basic EPS from Cont Ops	0.97	2.26	1.48	-0.25	-0.06	0.22	0.08	-0.14	0.99	0.02	1.32	1.88	2.85	3.29	2.1
Diluted EPS, GAAP	0.97	2.26	1.48	-0.25	-0.06	0.21	0.08	-0.12	0.98	0.03	1.25	1.74	2.6	3.06	2.03
Diluted EPS from Cont Ops	0.97	2.26	1.48	-0.25	-0.06	0.21	0.08	-0.14	0.93	0.02	1.27	1.74	2.6	3.06	2.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.39	-0.21	3.88	0.5	0.24	0.85	0.85	0.82	0.89	1.22	2.05	1.84	3.8	4.41	3.34
Free Cash Flow per Basic Share	1.14	-3.29	1.68	0.01	-0.12	0.38	0.09	-0.19	- -	0.5	1.48	1.34	3.01	3.56	2.55
Cash & Equivalents per Share	- -	1.16	1.2	1.52	1.46	1.58	1.46	1.91	1.83	2.22	2.86	3.65	5.34	4.65	6.2
Book Value per Share	- -	5.38	5.64	6.31	6.54	7.12	7.16	7.13	8.19	8.47	9.34	10.99	13.3	15.38	17.28
Tangible Book Value per Share	- -	4.4	4.74	5.36	5.66	6.03	6.19	6.22	7.3	7.62	8.52	10.21	0.54	2.97	4.88

Amphastar Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)